| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ISHARES TR | 350,000 | 40,243,000 | 11.62% | Put | |
| 2 | SPDR SER TR | 400,000 | 21,632,000 | 6.25% | Put | |
| 3 | SPDR S&P 500 ETF TR | 100,000 | 20,948,000 | 6.05% | Put | |
| 4 | GW PHARMACEUTICALS PLC | 130,000 | 11,904,000 | 3.44% | Put | |
| 5 | OPHTHOTECH CORP COM | 215,000 | 10,971,000 | 3.17% | ||
| 6 | ALEXION PHARMACEUTIC | 90,000 | 10,508,000 | 3.03% | ||
| 7 | NUVASIVE INC COM | 150,000 | 8,958,000 | 2.59% | ||
| 8 | MEDTRONIC PLC | 100,000 | 8,677,000 | 2.51% | ||
| 9 | BIOMARIN | 110,000 | 8,558,000 | 2.47% | ||
| 10 | EDWARDS LIFESCIENCES CORP | 85,000 | 8,477,000 | 2.45% | ||
| 11 | CONMED CORP | 175,000 | 8,353,000 | 2.41% | ||
| 12 | ACORDA THERAPEUTICS | 325,000 | 8,289,000 | 2.39% | ||
| 13 | BOSTON SCIENTIFIC CORP | 350,000 | 8,180,000 | 2.36% | Call | |
| 14 | BOSTON SCIENTIFIC CORP | 325,000 | 7,595,000 | 2.19% | ||
| 15 | AXOVANT SCIENCES LTD | 575,000 | 7,383,000 | 2.13% | ||
| 16 | BLUEBIRD BIO INCORPORATED | 170,000 | 7,359,000 | 2.13% | ||
| 17 | BIOGEN INC | 30,000 | 7,255,000 | 2.10% | ||
| 18 | SPECTRANETICS CORP | 375,000 | 7,016,000 | 2.03% | ||
| 19 | CLOVIS ONCOLOGY INC | 500,000 | 6,860,000 | 1.98% | Put | |
| 20 | CLOVIS ONCOLOGY INC | 450,000 | 6,174,000 | 1.78% | ||
| 21 | NEVRO CORP | 80,000 | 5,901,000 | 1.70% | ||
| 22 | SAREPTA THERAPEUTICS INC | 300,000 | 5,721,000 | 1.65% | Put | |
| 23 | NEUROCRINE BIOSCIE COM USD0.001 | 125,000 | 5,681,000 | 1.64% | ||
| 24 | Lion Biotechnologies | 700,000 | 5,670,000 | 1.64% | ||
| 25 | K2M GROUP HLDGS INC COM | 350,000 | 5,432,000 | 1.57% | ||
| 26 | GENOMIC HEALTH INC COM | 200,000 | 5,179,000 | 1.50% | ||
| 27 | INTERCEPT PHARMACEUTICAL | 35,000 | 4,994,000 | 1.44% | Call | |
| 28 | ENDOLOGIX INC | 400,000 | 4,984,000 | 1.44% | ||
| 29 | BIOCRYST PHARMACEUTICALS | 1,700,000 | 4,828,000 | 1.39% | ||
| 30 | INTRA CELLULAR THERAPIES INC COM | 120,000 | 4,658,000 | 1.35% | ||
| 31 | SAGE THERAPEUTICS | 150,000 | 4,520,000 | 1.31% | Call | |
| 32 | Wright Medical Group NV | 250,000 | 4,343,000 | 1.25% | ||
| 33 | TESARO INC | 50,000 | 4,203,000 | 1.21% | Call | |
| 34 | TESARO INC | 50,000 | 4,203,000 | 1.21% | ||
| 35 | HORIZON PHARMA PLC | 250,000 | 4,118,000 | 1.19% | ||
| 36 | PACIRA BIOSCIENCES INC | 120,000 | 4,048,000 | 1.17% | ||
| 37 | SAREPTA THERAPEUTICS INC | 200,000 | 3,814,000 | 1.10% | ||
| 38 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 350,000 | 3,759,000 | 1.09% | ||
| 39 | HORIZON PHARMA PLC | 200,000 | 3,294,000 | 0.95% | Call | |
| 40 | RAPTOR PHARMACEUTICAL CORP | 600,000 | 3,222,000 | 0.93% | ||
| 41 | NANOSTRING TECHNOLOGIES INC | 250,000 | 3,150,000 | 0.91% | ||
| 42 | CELGENE CORP | 25,000 | 2,466,000 | 0.71% | ||
| 43 | IMMUNOMEDICS INC | 1,000,000 | 2,320,000 | 0.67% | ||
| 44 | ENTELLUS MEDICAL INC | 120,000 | 2,192,000 | 0.63% | ||
| 45 | SAREPTA THERAPEUTICS INC | 100,000 | 1,907,000 | 0.55% | Call | |
| 46 | INTERCEPT PHARMACEUTICAL | 12,700 | 1,812,000 | 0.52% | ||
| 47 | RIGEL PHARMACEUTICAL INC | 800,000 | 1,784,000 | 0.52% | ||
| 48 | VERACYTE INC | 341,708 | 1,719,000 | 0.50% | ||
| 49 | FLUIDIGM CORP DEL COM | 150,000 | 1,355,000 | 0.39% | ||
| 50 | ALCOBRA LTD | 300,000 | 1,347,000 | 0.39% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-16-006501, filed 2016.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
